Tuesday, October 30, 2012
Insurance Policies Favoring Compounded Drugs For High-Risk Pregnancies Draw Scrutiny
When a brand-name drug to help prevent premature births was approved last year, its $1,500-a-dose-price alarmed state and private sector insurance officials.
Many restricted use of the FDA-approved Makena in favor of $20- to $40-a-dose versions that had been made for years by pharmacies, saying that would give more women access to the treatment. Federal officials, sympathetic to such arguments, allowed the pharmacies to continue making the unapproved drugs.
Clink here to continue reading
Zoeller: Suspend License Of Pharmacy That Produced Tainted Steroids
Last updated on Tuesday, October 30, 2012
(INDIANAPOLIS) - Attorney General Greg Zoeller wants the Indiana Pharmacy Board to suspend the license of a questionable Massachusetts pharmacy.
The pharmacy is linked to the meningitis outbreak. Zoeller filed an emergency petition Friday.
He says the New England Compounding Center produced the tainted steroid that has been linked to fungal meningitis.
The non-resident pharmacy distributes its products in Indiana and has already suspended operations.
The Indiana Department of Health says the state now has 43 cases and three deaths stemming from the nationwide outbreak. Zoeller says the NECC presents an immediate danger to public health and safety.
CLick here to continue reading
Insurer Sues Compounding Pharmacy over Coverage for Fungi-Contaminated Injection Claims
October 30, 2012
Download a PDF Version of this Article 
OCALA, Fla. — Evanston Insurance Co. has filed a federal lawsuit requesting a ruling that it has no obligation to defend a Florida-based compounding pharmacy against claims by individuals who were allegedly infected by fungus-contaminated injections.
The lawsuit, filed Oct. 26 in U.S. District Court for the Middle District of Florida, alleges that coverage of at least seven claims and two underlying personal injury suits against Franck’s Lab Inc. is barred by a mold and fungi exclusion contained in policies it sold the company and its related entities.
Evanston says it wants the federal court to declare that it has ...http://harrismartin.com/article/15331/insurer-sues-compounding-pharmacy-over-coverage-for-fungi-contaminated-injection-claims/
Subscribe to:
Posts (Atom)